| Item Type | Name |
|
Concept
|
CD4 Lymphocyte Count
|
|
Academic Article
|
T cell responses to recall antigens, alloantigen, and mitogen of HIV-infected patients receiving long-term combined antiretroviral therapy.
|
|
Academic Article
|
Immune reconstitution in the first year of potent antiretroviral therapy and its relationship to virologic response.
|
|
Academic Article
|
Monitoring HIV-1 treatment in immune-cell subsets with ultrasensitive fluorescence-in-situ hybridisation.
|
|
Academic Article
|
Immunophenotypic markers and antiretroviral therapy (IMART): T cell activation and maturation help predict treatment response.
|
|
Academic Article
|
Pretreatment levels of soluble cellular receptors and interleukin-6 are associated with HIV disease progression in subjects treated with highly active antiretroviral therapy.
|
|
Academic Article
|
Immune restoration following treatment. Abstract and Commentary.
|
|
Academic Article
|
CD4 enumeration technologies: a systematic review of test performance for determining eligibility for antiretroviral therapy.
|
|
Academic Article
|
Perforin is not co-expressed with granzyme A within cytotoxic granules in CD8 T lymphocytes present in lymphoid tissue during chronic HIV infection.
|
|
Academic Article
|
Prediction of CD4 count from CD4 percentage: experience from three laboratories.
|
|
Academic Article
|
Immune reconstitution is comparable in antiretroviral-naive subjects after 1 year of successful therapy with a nucleoside reverse-transcriptase inhibitor- or protease inhibitor-containing antiretroviral regimen.
|
|
Academic Article
|
Effect of menstrual cycle on HIV-1 levels in the peripheral blood and genital tract. WHS 001 Study Team.
|
|
Academic Article
|
A randomized study of antiviral medication switch at lower- versus higher-switch thresholds: AIDS Clinical Trials Group Study A5115.
|
|
Academic Article
|
Hepatic fibrosis and immune phenotype vary by HCV viremia in HCV/HIV co-infected subjects: A Women's interagency HIV study.
|
|
Academic Article
|
An altered intestinal mucosal microbiome in HIV-1 infection is associated with mucosal and systemic immune activation and endotoxemia.
|
|
Academic Article
|
In vitro restoration of T cell immune function in human immunodeficiency virus-positive persons: effects of interleukin (IL)-12 and anti-IL-10.
|
|
Academic Article
|
Relationship of HIV RNA and cytokines in saliva from HIV-infected individuals.
|
|
Academic Article
|
Changes in human immunodeficiency virus type 1 virus load during mobilization and harvesting of hemopoietic progenitor cells. Adult AIDS Clinical Trials Group 285 Study Team.
|
|
Academic Article
|
Immunologic responses associated with 12 weeks of combination antiretroviral therapy consisting of zidovudine, lamivudine, and ritonavir: results of AIDS Clinical Trials Group Protocol 315.
|
|
Academic Article
|
CD4 immunophenotyping in HIV infection.
|
|
Academic Article
|
A randomized controlled trial of palifermin (recombinant human keratinocyte growth factor) for the treatment of inadequate CD4+ T-lymphocyte recovery in patients with HIV-1 infection on antiretroviral therapy.
|
|
Academic Article
|
Evaluating the impact of hepatitis C virus (HCV) on highly active antiretroviral therapy-mediated immune responses in HCV/HIV-coinfected women: role of HCV on expression of primed/memory T cells.
|
|
Academic Article
|
Determinants of CD4+ T cell recovery during suppressive antiretroviral therapy: association of immune activation, T cell maturation markers, and cellular HIV-1 DNA.
|
|
Academic Article
|
The relation of plasmacytoid dendritic cells (pDCs) and regulatory T-cells (Tregs) with HPV persistence in HIV-infected and HIV-uninfected women.
|
|
Academic Article
|
Maximum suppression of HIV replication leads to the restoration of HIV-specific responses in early HIV disease.
|
|
Academic Article
|
The virologic, immunologic, and clinical effects of interleukin 2 with potent antiretroviral therapy in patients with moderately advanced human immunodeficiency virus infection: a randomized controlled clinical trial--AIDS Clinical Trials Group 328.
|
|
Academic Article
|
PDL-1 upregulation on monocytes and T cells by HIV via type I interferon: restricted expression of type I interferon receptor by CCR5-expressing leukocytes.
|
|
Academic Article
|
Intracellular Casp8p41 content is inversely associated with CD4 T cell count.
|
|
Academic Article
|
Standardization of absolute CD4+ lymphocyte counts across laboratories: an evaluation of the Ortho CytoronAbsolute flow cytometry system on normal donors.
|
|
Academic Article
|
A North American multilaboratory study of CD4 counts using flow cytometric panLeukogating (PLG): a NIAID-DAIDS Immunology Quality Assessment Program Study.
|
|
Academic Article
|
GBV-C viremia is associated with reduced CD4 expansion in HIV-infected people receiving HAART and interleukin-2 therapy.
|
|
Academic Article
|
Role of Baseline pol Genotype in HIV-1 Fitness Evolution.
|
|
Academic Article
|
Effect of zidovudine therapy on CD8+ T cell anti-HIV activity.
|
|
Academic Article
|
Short communication: Apoptosis pathways in HIV-1-infected patients before and after highly active antiretroviral therapy: relevance to immune recovery.
|
|
Academic Article
|
A matched cross-sectional study of the association between circulating tissue factor activity, immune activation and advanced liver fibrosis in hepatitis C infection.
|
|
Academic Article
|
Association of chronic hepatitis C infection with T-cell phenotypes in HIV-negative and HIV-positive women.
|
|
Academic Article
|
Can immune markers predict subsequent discordance between immunologic and virologic responses to antiretroviral therapy? Adult AIDS Clinical Trials Group.
|
|
Academic Article
|
MDR1 gene polymorphisms and phase 1 viral decay during HIV-1 infection: an adult AIDS Clinical Trials Group study.
|
|
Academic Article
|
Immunogenetics of CD4 lymphocyte count recovery during antiretroviral therapy: An AIDS Clinical Trials Group study.
|
|
Academic Article
|
Delaying a treatment switch in antiretroviral-treated HIV type 1-infected patients with detectable drug-resistant viremia does not have a profound effect on immune parameters: AIDS Clinical Trials Group Study A5115.
|
|
Academic Article
|
Interleukin 10 responses are associated with sustained CD4 T-cell counts in treated HIV infection.
|
|
Academic Article
|
The effect of aging on T-regulatory cell frequency in HIV infection.
|
|
Academic Article
|
HIV-1-infected antiretroviral-treated patients with prolonged partial viral suppression: clinical, virologic, and immunologic course.
|
|
Academic Article
|
Hepatitis G virus RNA is common in AIDS patients' plasma but is not associated with abnormal liver function tests or other clinical syndromes.
|
|
Academic Article
|
Impact of class A, B and C CpG-oligodeoxynucleotides on in vitro activation of innate immune cells in human immunodeficiency virus-1 infected individuals.
|
|
Academic Article
|
Interleukin-2 Increases CD4+ lymphocyte numbers but does not enhance responses to immunization: results of A5046s.
|
|
Academic Article
|
Activation of CD8 T cells predicts progression of HIV infection in women coinfected with hepatitis C virus.
|
|
Academic Article
|
Characterization of viral dynamics in human immunodeficiency virus type 1-infected patients treated with combination antiretroviral therapy: relationships to host factors, cellular restoration, and virologic end points.
|
|
Academic Article
|
HIV-1 in genital tract and plasma of women: compartmentalization of viral sequences, coreceptor usage, and glycosylation.
|
|
Academic Article
|
In vitro cell-mediated immune responses of human immunodeficiency virus-infected and -uninfected individuals to whole cytomegalovirus antigens and their subunits.
|
|
Academic Article
|
Correlates of immune activation marker changes in human immunodeficiency virus (HIV)-seropositive and high-risk HIV-seronegative women who use illicit drugs.
|
|
Academic Article
|
Granulocyte-macrophage colony-stimulating factor induces modest increases in plasma human immunodeficiency virus (HIV) type 1 RNA levels and CD4+ lymphocyte counts in patients with uncontrolled HIV infection.
|
|
Academic Article
|
Metabolic effects of darunavir/ritonavir versus atazanavir/ritonavir in treatment-naive, HIV type 1-infected subjects over 48 weeks.
|
|
Academic Article
|
Reduced mobilization of CD34+ stem cells in advanced human immunodeficiency virus type 1 disease.
|
|
Academic Article
|
Evaluation of immunologic markers in cervicovaginal fluid of HIV-infected and uninfected women: implications for the immunologic response to HIV in the female genital tract.
|
|
Academic Article
|
A pilot trial of adding maraviroc to suppressive antiretroviral therapy for suboptimal CD4? T-cell recovery despite sustained virologic suppression: ACTG A5256.
|
|
Academic Article
|
Multiple CD4+ cell kinetic patterns and their relationships with baseline factors and virological responses in HIV type 1 patients receiving highly active antiretroviral therapy.
|
|
Academic Article
|
Differential CD4+ cell count increase and CD4+?: ?CD8+ ratio normalization with maraviroc compared with tenofovir.
|
|
Academic Article
|
Interferon-alpha administration enhances CD8+ T cell activation in HIV infection.
|
|
Academic Article
|
Evidence of a selective depletion of a CD16+ CD56+ CD8+ natural killer cell subset during HIV infection.
|
|
Academic Article
|
A potential role for interleukin-7 in T-cell homeostasis.
|
|
Academic Article
|
Depletion of latent HIV-1 infection in vivo: a proof-of-concept study.
|
|
Academic Article
|
Evaluation of the impact of highly active antiretroviral therapy on immune recovery in antiretroviral naive patients.
|
|
Academic Article
|
Cellular restoration in HIV infected persons treated with abacavir and a protease inhibitor: age inversely predicts naive CD4 cell count increase.
|
|
Academic Article
|
Resumption of HIV replication is associated with monocyte/macrophage derived cytokine and chemokine changes: results from a large international clinical trial.
|
|
Academic Article
|
Early and delayed benefits of HIV-1 suppression: timeline of recovery of innate immunity effector cells.
|
|
Academic Article
|
The effect of HIV infection and HAART on inflammatory biomarkers in a population-based cohort of women.
|
|
Academic Article
|
A look at HIV immune research. Interview by Alan Huff.
|
|
Academic Article
|
In vivo analysis of Fas/FasL interactions in HIV-infected patients.
|
|
Academic Article
|
Immunologic and virologic evaluation after influenza vaccination of HIV-1-infected patients.
|
|
Academic Article
|
Long-term changes in circulating CD4 T lymphocytes in virologically suppressed patients after 6 years of highly active antiretroviral therapy.
|
|
Academic Article
|
Increased glucose transporter-1 expression on intermediate monocytes from HIV-infected women with subclinical cardiovascular disease.
|
|
Academic Article
|
Polymorphism rs1385129 Within Glut1 Gene SLC2A1 Is Linked to Poor CD4+ T Cell Recovery in Antiretroviral-Treated HIV+ Individuals.
|
|
Academic Article
|
A Randomized, Double-blinded, Placebo-controlled Trial of Sitagliptin for Reducing Inflammation and Immune Activation in Treated and Suppressed Human Immunodeficiency Virus Infection.
|
|
Academic Article
|
Vitamin D does not modulate immune-mediated bone loss during ART initiation.
|
|
Academic Article
|
Antiretroviral Therapy Reduces T-cell Activation and Immune Exhaustion Markers in Human Immunodeficiency Virus Controllers.
|
|
Academic Article
|
T Lymphocyte Subsets Associated With Prevalent Diabetes in Veterans With and Without Human Immunodeficiency Virus.
|
|
Academic Article
|
Effects of cocaine and HIV on decision-making abilities.
|
|
Academic Article
|
The Hitchhiker Guide to CD4+ T-Cell Depletion in Lentiviral Infection. A Critical Review of the Dynamics of the CD4+ T Cells in SIV and HIV Infection.
|
|
Academic Article
|
Elevated CD4 + T-cell glucose metabolism in HIV+ women with diabetes mellitus.
|